Eden democratizes access to physician-guided treatments that support people in achieving their health goals, helping them feel and perform at their best. Ready to feel like you again
Heart disease and stroke are expected to cost our healthcare system $473 billion in 2009
How Retatrutide Compares to Current GLP1 and DualAgonist Drugs Current injectable weightloss drugs can be grouped roughly as: GLP1 single agonists semaglutide (Ozempic, Wegovy), liraglutide, etc
for MetS and T2D), and because exercise is one of the most potent IGF-1 synthesis/freeing mechanisms, it seems logical to correlate them and establish IGF-1 as a target for future options in the multifactorial treatment for metabolic syndrome
Thomas, T., Thomas, G., McLendon, C., Sutton, T
One of the most consistent patterns I see is patients who come to us specifically because they couldnt tolerate semaglutide elsewhere typically due to nausea